Dipna Pharmachem Ltd
DIPN

Dipna Pharmachem Ltd (543594)

₹216.6%

Key Stats

₹20
Day's Price Range
₹21.5
₹18.4
52-Week Price Range
₹33.6
1 Month Return0.25 %

Company Financials

  • Annual
Total Assets
Total Liabilities
Value in ₹ crore

Peer Comparsion

PE
Rank 4
EPS
Rank 4
BVPS
Rank 7
Dividend Yield
Rank 2
ROE
Rank 3
100.86%
Debt To Asset
Rank 1
0.95

Company Information

Dipan Pharmachem Private Limited was incorporated under the provisions of Companies Act 1956 dated July 19 2011. Subsequently the name of company was changed to Dipna Pharmachem Private Limited on March 29 2012. Later on the Company converted from Private Limited to Public Limited and consequently the name of Company was changed to Dipna Pharmachem Limited vide fresh Certificate of Incorporation issued by Registrar of Companies Ahmedabad dated May 25 2022. Mr. Keyur Shah being the Promoter the Company is engaged in trading and distribution of pharmaceutical raw material and chemical formulation products also known as APIs Active Pharmaceutical Ingredients. Presently its product portfolio comprises of 61 AIPs and AIPs intermediates such as Cephalosporins Cardiovasculars Anti Bactaria Quinolones Veterinary Anti Virus Anti Inflammatory Neuropsychiatry Steroid Hormone other etc. Being a trading and distribution company it has a pan India market for products. In FY 2022 the Company had started the selling of chemicals on commission basis and is presently doing trading in Ahmedabad.
OrganisationDipna Pharmachem Ltd
HeadquartersAhmedabad
IndustryTrading

Indian stocks brokerage services are provided by INDmoney Private Limited. INDmoney Private Limited is carrying out the business of in respect to stock broking activities and also carries out the activities of depository participant. SEBI Registration No. INZ000305337 | SEBI Depository Participant Registration No. IN-DP-690-2022 Depository Participant ID: CDSL 12095500 | Trading and Clearing Member of NSE (90267, M70042) and BSE (6779)

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. The securities quoted are exemplary and not recommendatory. Past performance is not indicative of future returns.